C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2002
11/13/2002	EP1255864A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255859A2 Tissue specific genes of diagnostic import
11/13/2002	EP1255848A2 Methods for enhancing the production of cytokines in cell cultur e
11/13/2002	EP1255844A1 Humanized anti-ccr2 antibodies and methods of use therefor
11/13/2002	EP1255842A1 Larynx carcinoma-associated protein larcap-1
11/13/2002	EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
11/13/2002	EP1255837A2 Il-17 like molecules and uses thereof
11/13/2002	EP1255835A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255834A2 Gtpase activating proteins
11/13/2002	EP1255833A2 Polypeptides and nucleic acids encoding same
11/13/2002	EP1255831A2 Sperm specific proteins
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255817A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255816A1 Tailored peptide synthetases, a method for their production and the use thereof
11/13/2002	EP1255780A1 Methods and compositions for generating human monoclonal antibodies
11/13/2002	EP1255778A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255777A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255776A1 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255771A1 Novel compounds
11/13/2002	EP1255768A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255767A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255766A2 Nucleic acids, proteins, and antibodies
11/13/2002	EP1255558A1 Uses of agonists and antagonists to modulate activity of tnf-related molecules
11/13/2002	EP1060261A4 Poly zinc finger proteins with improved linkers
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/13/2002	EP0584284B9 Recombinant dna-derived cholera toxin subunit analogs
11/13/2002	EP0449958B2 Meningococcal class 1 outer-membrane protein vaccine
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379811A Novel yeast variants and process for producing glycoprotein containing mammalian type sugar chain
11/13/2002	CN1379685A Novel method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and beta integrins
11/13/2002	CN1379112A Process for preparing peptide antibiotics with efficient expression
11/13/2002	CN1379091A Refractory arginine inhibitor gene and its polypeptide coded by it and preparing process
11/13/2002	CN1379087A Arrhythmia-resistant scorpion peptide recombined colibacillus and its configuring process
11/13/2002	CN1379042A Scorpion peptide for treating arrhythmia and its preparing process and application
11/12/2002	US6480791 Parallel methods for genomic analysis
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479639 Monoclonal antibody to a human MDR1 multidrug resistance gene product and uses
11/12/2002	US6479635 Receptor activator of NF-κB
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479626 Poly zinc finger proteins with improved linkers
11/12/2002	US6479459 Cytokine designated lerk-5
11/12/2002	US6479291 Cytoplasmic inhibition of gene expression by viral RNA
11/12/2002	US6479284 Humanized antibody and uses thereof
11/12/2002	US6479283 Stimulation, culture and preservation of pancreatic cells
11/12/2002	US6479282 Hbc expression and diagnostic and therapeutic uses
11/12/2002	US6479263 Method for detection of micrometastatic prostate cancer
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002	US6479258 Non-stochastic generation of genetic vaccines
11/12/2002	US6479250 Eck receptor ligands
11/12/2002	US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002	US6479245 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
11/12/2002	CA2220684C Process for controlling sialylation of proteins produced by mammalian cell culture
11/12/2002	CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002	CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/12/2002	CA2055963C Chimeric fibroblast growth factor
11/12/2002	CA2045875C Monoclonal antibodies to mycosphaerella species
11/07/2002	WO2002088706A2 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002	WO2002088375A2 Compositions and methods relating to breast specific genes and proteins
11/07/2002	WO2002088369A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants
11/07/2002	WO2002088367A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus
11/07/2002	WO2002088351A1 Modified organs and cells for xenotransplantation
11/07/2002	WO2002088346A2 A system for inducible expression in eukaryotic cells
11/07/2002	WO2002088342A1 An enzyme preparation for improved baking quality and a process for preparing the same
11/07/2002	WO2002088340A2 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
11/07/2002	WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002	WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088310A2 Cobra gene and uses thereof
11/07/2002	WO2002088306A2 Humanized antibodies
11/07/2002	WO2002088302A2 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
11/07/2002	WO2002088186A1 Anti-cd40 monoclonal antibody
11/07/2002	WO2002088185A2 Pan-specific monoclonal antibody
11/07/2002	WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002	WO2002088168A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
11/07/2002	WO2002087615A1 Human polyclonal antibody compositions
11/07/2002	WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002	WO2002087502A2 Antibodies abolish prion propagation and promote clearance of infectivity
11/07/2002	WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002	WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2002012899A3 Peptides presented by cells
11/07/2002	WO2001049830A9 Improved lysosomal enzymes and lysosomal enzyme activators
11/07/2002	US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002	US20020166130 Expression of active human factor IX in mammary tissue of transgenic animals
11/07/2002	US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002	US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002	US20020165378 Human membrane antigen tm4 superfamily protein and dna encoding this protein
11/07/2002	US20020165374 Secreted protein HFEAF41
11/07/2002	US20020165373 Contacting the sample with an isolated recombinant immunodominant Neospora antigen, forming an antigen/antibody complex, and detecting the presence or absence of the complex
11/07/2002	US20020165363 Cachexia remedy
11/07/2002	US20020165361 Antibody for use in the diagnosis and treatment of cell proliferation disorders
11/07/2002	US20020165359 Gelatin for use in the generation of films on capsules
11/07/2002	US20020165356 Zinc finger binding domains for nucleotide sequence ANN

1 ... 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 ... 1125